Analysis of Tilray share price

72% of retail investor accounts lose money when trading CFDs with this provider.
Chart provided by Tradingview

Elements that can influence the price of this asset:

Analysis N°1

First of all, we will pay attention to the evolution of medical cannabis and recreational cannabis legislation around the world. In fact, the more countries that allow authorized and legal cannabis use, the more companies like Tilray, already well established on the market, will be able to make profits.

Analysis N°2

The development of new hemp products by the Tilray company will also be important if you want to build on this action. Indeed, the diversification strategy that the group is implementing in this direction can multiply the sources of income and allow its growth.

Analysis N°3

We will of course keep an eye on the competition in this sector which is likely to increase sharply as demand increases with an analysis of the current main players and potential future competitors.

Analysis N°4

Finally, we will of course also follow the publication of the group's financial and economic results with the annual balance sheet and the quarterly or half-yearly results as well as the objectives set internally.

72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500

General presentation of Tilray

We now invite you to learn a little more about the Tilray company and its economic environment. We will present to you in detail this company and its sources of income with its main activities and the various products which it markets as well as the markets on which it exercises.

The Tilray Inc group is a Canadian company specialized in the pharmaceutical sector and which more specifically offers cannabis-based products to pharmaceutical distributors. As such, the Tilray company carries out medical research on cannabis, cultivation of cannabis, and further processing and marketing of cannabis products worldwide.

Tilray also has a subsidiary called FHF Holdings Ltd which manufactures, markets and distributes consumer hemp products. Among the products in this company's portfolio are hemp heart, hemp oil, hemp granola, hemp protein powder and hemp milk. The company also markets cannabis to patients in certain countries around the world through subsidiaries located in Australia, Canada and Germany. The group's medical cannabis is produced in Canada and Europe. To date, the Tilray group employs nearly 1,646 people.

Regarding the distribution of turnover by type of product, we find at the top the sale of pure cannabis with 49.6% of turnover, the sale of hemp products for 35.8% of turnover, the sale of extracts cannabis for 14.5% of turnover and the sale of accessories and other products for 0.2% of turnover.

Finally, with regard to the geographic distribution of the group's revenues, we note that 78% comes from Canada, 14.1% from the United States and 7.9% from the rest of the world.

Analysis of Tilray share price
72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500

The major competitors of Tilray

We now offer you a better understanding of the sector of activity in which the Tilray Inc group operates, namely, the sector of production and sale of medical cannabis or cannabis-based products. There are indeed several large companies also specialized in this type of activity and which are direct competitors of Tilray. The classification of these companies by turnover is as follows:

 Aurora Cannabis 

is also a Canadian company and number two in the market.


is the fifth largest cannabis company in the world.

CannTrust Holdings

comes in sixth position in the ranking.


Finally, the Cronos group, also Canadian, is the seventh largest in this sector in the world.

The major partners of Tilray

Of course, the Tilray group does not only have enemies on the market and can also count on certain strategic partnerships that allow it to maintain or grow its activity over time. These partnerships are of the utmost importance as they are often followed by investors as strong buy signals. Here are just a few recent examples:

AB InBev

In 2019, the Tilray group announced a strategic partnership with the Belgian-Brazilian group AB InBev which is notably the operator of the beer brands Budweiser, Stella Artois or Corona in the context of research on non-alcoholic beverages with cannabis. As part of this partnership, each of these two companies invested $ 50 million in order to develop a product for the Canadian market alone as a first step.

 Alef Biotechnology Spa 

It is a former partner of Tilray which was finally acquired in 2019 by this Canadian group. This company specializes in import and distribution. This acquisition has enabled Tilray to strengthen its positioning among the leaders in medical cannabis worldwide.

Natura Naturals

 Again, this is more of a strategic acquisition than a real partnership since Natura Naturals was acquired by Tilray in 2018. Following this transaction and the finalization of this agreement which took place 12 months after this announcement, Tilray has paid for the purchase of this subsidiary which will allow it to significantly reduce its production costs by benefiting from a supplier which is directly attached. This initiative has in fact increased Tilray's production capacities and ensured it some growth in light of the growing demand from Canadian consumers and industry.

72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500

Frequently Asked Questions

How to analyze the Tilray stock and its evolution?

To effectively and conclusively analyze the Tilray share price and its likely evolution in the future, you need to set up a method based on both fundamental analysis and technical analysis of this value. It is indeed advisable to systematically compare the signals obtained by means of these two methods for more precision during your decision-making and position.

Can i buy Tilray shares in UK?

If there are few stock portfolios accessible in UK and offering the Tilray share or any other share of a Canadian company specializing in cannabis, you still have the possibility of investing in this value through online trading platforms and with CFD contracts. These contracts allow you to access almost all the equity markets in the world.

Are the Tilray group's profit and loss accounts accessible?

Like all listed companies, the Tilray group is obliged to publish its annual and quarterly financial results in a transparent manner. You will find these detailed results in the “investors” section of its website as well as on the website of your broker or any other specialized stock market news site.

72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. This is an advert for trading CFDs on Plus500